Janus Henderson Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Hold |
47,957
| – | – | ﹤0.01% | 2001 |
|
|
2025
Q1 | $387K | Hold |
47,957
| – | – | ﹤0.01% | 2087 |
|
|
2024
Q4 | $560K | Hold |
47,957
| – | – | ﹤0.01% | 1981 |
|
|
2024
Q3 | $985K | Buy |
47,957
+10,575
| +28% | +$217K | ﹤0.01% | 1676 |
|
|
2024
Q2 | $837K | Sell |
37,382
-459
| -1% | -$10.3K | ﹤0.01% | 1715 |
|
|
2024
Q1 | $1.04M | Buy |
37,841
+6
| +0% | +$165 | ﹤0.01% | 1623 |
|
|
2023
Q4 | $1.15M | Sell |
37,835
-38
| -0.1% | -$1.16K | ﹤0.01% | 1547 |
|
|
2023
Q3 | $1.2M | Buy |
37,873
+2
| +0% | +$63 | ﹤0.01% | 1465 |
|
|
2023
Q2 | $1.54M | Buy |
37,871
+6,572
| +21% | +$268K | ﹤0.01% | 1377 |
|
|
2023
Q1 | $1.17M | Sell |
31,299
-22,846
| -42% | -$851K | ﹤0.01% | 1543 |
|
|
2022
Q4 | $1.89M | Buy |
54,145
+29,283
| +118% | +$1.02M | ﹤0.01% | 1114 |
|
|
2022
Q3 | $1.39M | Buy |
24,862
+12,425
| +100% | +$696K | ﹤0.01% | 1479 |
|
|
2022
Q2 | $644K | Buy |
12,437
+17
| +0.1% | +$880 | ﹤0.01% | 1596 |
|
|
2022
Q1 | $902K | Sell |
12,420
-258,581
| -95% | -$18.8M | ﹤0.01% | 1561 |
|
|
2021
Q4 | $32M | Sell |
271,001
-6,826
| -2% | -$807K | 0.01% | 677 |
|
|
2021
Q3 | $37.3M | Buy |
277,827
+24,730
| +10% | +$3.32M | 0.02% | 634 |
|
|
2021
Q2 | $41M | Buy |
253,097
+217,437
| +610% | +$35.2M | 0.02% | 623 |
|
|
2021
Q1 | $2.86M | Buy |
+35,660
| New | +$2.86M | ﹤0.01% | 1123 |
|